Aro Biotherapeutics Funding & Investors
Philadelphia, PA
Unlocking the Potential of Genetic Medicines Based in Philadelphia, Aro Biotherapeutics is a biotechnology company pioneering the development of tissue-targeted genetic medicines with a platform based on a proprietary protein technology called Centyrins.
arobiotx.comTotal Amount Raised: $166,500,000
Aro Biotherapeutics Funding Rounds
Series B
$41,500,000
Series B Investors
Cowen Healthcare InvestmentsBVF PartnersNorthpond VenturesHealthCapJohnson & Johnson Innovation – JJDCSeries B
$24,000,000
Series B Investors
Cowen Healthcare InvestmentsSeries A
$88,000,000
Series A Investors
Cowen Healthcare InvestmentsNorthpond VenturesBioMotivRidgeback Capital ManagementIsis PharmaceuticalsBiotechnology Value FundJohnson & Johnson Robotics and Digital SolutionsHealthCapSeries Unknown
$13,000,000
Series Unknown Investors
BioMotivJohnson & Johnson Robotics and Digital Solutions
Funding info provided by Diffbot.